In this study, we show that 14 BTN2A1, 10 BTN3A1, and 13 BTN3A2 SNPs are significantly associated with CeD status, while HV4 sequence variation was not associated with CeD risk. This evidence concerns the gene BTN2A1 and cranioectodermal dysplasia.